diagnostic

CMS released a second Interim Final Rule on COVID-19 with additional waivers, giving more flexibility to providers

April 30, 2020

McDermott+Consulting

This afternoon, CMS published a second interim final rule on COVID-19 with some key changes in the lab / diagnostic space:

  • Requirement that the test be ordered by a treating physician or nurse practitioner has been removed
  • COVD-19 tests as well as influenza and RSV testing will be covered when ordered by any health care professional authorized to do so under state law
  • Medicare will cover FDA-authorized serology tests for COVID-19 for individuals with known or suspected current or prior COVID-19 infection

Details on these changes and additional changes can be found in the interim final rule and the Laboratory Waivers document.

Medicare and Medicaid Programs, Basic Health Program, and Exchanges; Additional Policy and Regulatory Revisions in Response to the COVID-19 Public Health Emergency and Delay of Certain Reporting Requirements for the Skilled Nursing Facility Quality Reporting Program

Laboratories: Medicare Flexibilities to Fight COVID-19

Previous Post / Next Post
beakernav X1E2BFA62-BFCE-43C1-B777-27E3E5216018medical bagoriginal analysis +external linkpdf downloadstethoscope